Abstract
We tested the activity of BAL30072, a novel siderophore monobactam, against multiresistant clinical isolates of Pseudomonas aeruginosa, Burkholderia cepacia group and Acinetobacter spp. and against laboratory P. aeruginosa strains with defined resistance mechanisms.
| Original language | English |
|---|---|
| Pages (from-to) | 266-270 |
| Number of pages | 5 |
| Journal | Journal of Antimicrobial Chemotherapy |
| Volume | 65 |
| Issue number | 2 |
| DOIs | |
| Publication status | Published - Feb 2010 |
Keywords
- Acinetobacter
- Anti-Bacterial Agents
- Bacterial Proteins
- Burkholderia cepacia complex
- Drug Resistance, Multiple, Bacterial
- Gram-Negative Bacterial Infections
- Great Britain
- Humans
- Microbial Sensitivity Tests
- Monobactams
- Pseudomonas aeruginosa
- beta-Lactamases